Aspen Pharmacare will become a major African supplier of Merck’s experimental monthly HIV prevention pill, alimatravir. The agreement depends on the medicine successfully completing clinical trials and receiving regulatory approval. Merck granted voluntary licenses to...
Ebola treatment trials in the DRC need at least $18m in urgent funding to test experimental drugs and strengthen contact tracing. Subscription Required You must be a subscriber to access all of this content. View Subscriptions Already a subscriber? Log in...
Daraxonrasib Pancreatic Cancer Pill nearly doubled survival in metastatic PDAC, beating second-line chemo with fewer discontinuations. Subscription Required You must be a subscriber to access all of this content. View Subscriptions Already a subscriber? Log in...
Daraxonrasib pancreatic cancer trial results show that Revolution Medicines’ new therapy is doubling survival rates and reshaping oncology. Subscription Required You must be a subscriber to access all of this content. View Subscriptions Already a subscriber? Log...
South Africa launches the HIV vaccine trial, BRILLIANT 01, testing a new vaccine cocktail designed to prime broadly neutralising antibodies. Subscription Required You must be a subscriber to access all of this content. View Subscriptions Already a subscriber? Log in...
